| Views | |
|---|---|
| Long-term administration of the α-amylase inhibitor acarbose effective against type 2 diabetes symptoms in C57BL/6 mice | 59 |
| November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | |
|---|---|---|---|---|---|---|---|
| Long-term administration of the α-amylase inhibitor acarbose effective against type 2 diabetes symptoms in C57BL/6 mice | 7 | 0 | 1 | 10 | 2 | 3 | 2 |
| Views | |
|---|---|
| Borozdina_Long-term_24.pdf | 20 |
| Views | |
|---|---|
| Canada | 15 |
| United States | 11 |
| China | 4 |
| India | 4 |
| Russia | 3 |
| Germany | 2 |
| United Kingdom | 2 |
| Argentina | 1 |
| Brazil | 1 |
| EU | 1 |
| Views | |
|---|---|
| Ottawa | 14 |
| San Francisco | 3 |
| Thana | 3 |
| Englewood | 2 |
| Moscow | 2 |
| Mountain View | 2 |
| Ann Arbor | 1 |
| Beijing | 1 |
| Calgary | 1 |
| Cary | 1 |